NH Nongwoobio Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Other Revenue	0	-	-0	-	-	-
Revenue	157,775	158,789	144,680	135,844	133,400	132,843
Revenue Growth	6.17%	9.75%	6.50%	1.83%	0.42%	2.16%
Cost of Revenue	82,130	81,987	73,687	70,426	68,630	70,334
Gross Profit	75,645	76,802	70,994	65,417	64,770	62,509
Selling, General & Admin	41,784	41,291	38,605	36,096	33,730	35,409
Research & Development	17,875	17,623	17,770	17,375	17,198	17,150
Amortization of Goodwill & Intangibles	225	214	279	231	230	340
Other Operating Expenses	826	817	867	623	584	697
Operating Expenses	64,194	63,161	59,891	56,473	53,639	55,685
Operating Income	11,452	13,641	11,103	8,945	11,131	6,824
Interest Expense	-997	-983	-1,027	-1,385	-1,246	-973
Interest & Investment Income	850	1,033	862	593	385	212
Currency Exchange Gain (Loss)	889.35	-578	3,591	634.66	262.86	1,740
Other Non Operating Income (Expenses)	-479.61	130.56	-716.37	991.93	1,184	859.36
EBT Excluding Unusual Items	11,715	13,244	13,813	9,779	11,717	8,662
Gain (Loss) on Sale of Assets	2,097	2,100	236	1,016	523	64
Asset Writedown	-278	-278	-583	-815	-1,428	-1,145
Pretax Income	13,534	15,066	13,466	9,980	10,812	7,581
Income Tax Expense	1,298	2,783	2,557	-188.24	925.86	628.17
Earnings From Continuing Operations	12,235	12,283	10,909	10,169	9,886	6,953
Earnings From Discontinued Operations	-	-	-	152.77	-64.97	-
Net Income to Company	12,235	12,283	10,909	10,321	9,821	6,953
Minority Interest in Earnings	15.74	5.56	-69.6	11.24	57.54	-22.91
Net Income	12,251	12,289	10,839	10,333	9,879	6,930
Net Income to Common	12,251	12,289	10,839	10,333	9,879	6,930
Net Income Growth	2.23%	13.37%	4.90%	4.59%	42.54%	-26.27%
Shares Outstanding (Basic)	16	16	16	16	16	16
Shares Outstanding (Diluted)	16	16	16	16	16	16
Shares Change	0.03%	-0.03%	0.03%	-	-	-
EPS (Basic)	764.04	766.58	676.00	644.56	616.24	432.32
EPS (Diluted)	764.04	766.58	676.00	644.56	616.24	432.00
EPS Growth	2.21%	13.40%	4.88%	4.59%	42.65%	-26.28%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	4,963	9,946	11,402	10,197	5,066	167.19
Free Cash Flow Per Share	309.49	620.42	711.07	636.10	316.05	10.43
Dividend Per Share	-	-	-	200.000	200.000	200.000
Dividend Growth	-	-	-	0%	0%	0%
Gross Margin	47.95%	48.37%	49.07%	48.16%	48.55%	47.05%
Operating Margin	7.26%	8.59%	7.67%	6.59%	8.34%	5.14%
Profit Margin	7.76%	7.74%	7.49%	7.61%	7.41%	5.22%
Free Cash Flow Margin	3.15%	6.26%	7.88%	7.51%	3.80%	0.13%
EBITDA	18,045	20,161	17,308	14,318	17,101	13,732
EBITDA Margin	11.44%	12.70%	11.96%	10.54%	12.82%	10.34%
D&A For EBITDA	6,593	6,519	6,205	5,374	5,970	6,908
EBIT	11,452	13,641	11,103	8,945	11,131	6,824
EBIT Margin	7.26%	8.59%	7.67%	6.59%	8.34%	5.14%
Effective Tax Rate	9.59%	18.47%	18.99%	-	8.56%	8.29%
Advertising Expenses	-	930	992	970	937	1,442